What is the Trousseau sign and its clinical significance?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Trousseau Sign: Definition and Clinical Significance

Trousseau sign is a clinical manifestation of latent tetany caused by hypocalcemia, elicited by inflating a blood pressure cuff above systolic pressure for 3 minutes, resulting in carpopedal spasm with flexion of the wrist and metacarpophalangeal joints, extension of the interphalangeal joints, and adduction of the thumb.

Clinical Presentation and Elicitation

The Trousseau sign represents one of the cardinal physical examination findings for detecting neuromuscular irritability secondary to hypocalcemia 1. When the blood pressure cuff is inflated above systolic pressure, it induces ischemia in the nerves of the arm, which unmasks latent tetany in hypocalcemic patients 1. The resulting carpopedal spasm typically appears within 3 minutes and is characterized by:

  • Flexion at the wrist and metacarpophalangeal joints 1
  • Extension of the interphalangeal joints 1
  • Adduction of the thumb (creating the characteristic "obstetrician's hand" position) 1

Clinical Context and Associated Conditions

Hypocalcemia in Chronic Kidney Disease

Trousseau sign appears as a clinical indicator when corrected total serum calcium falls below 8.4 mg/dL (2.10 mmol/L) 1. In patients with chronic kidney disease (CKD) stages 3-5, the presence of Trousseau sign—along with other clinical symptoms such as paresthesia, Chvostek's sign, bronchospasm, laryngospasm, tetany, and/or seizures—mandates therapy to increase serum calcium levels 1.

The recommended therapeutic approach includes:

  • Calcium salts such as calcium carbonate 1
  • Oral vitamin D sterols 1

Distinction from Trousseau Syndrome

It is critical to distinguish Trousseau sign (a physical examination finding for hypocalcemia) from Trousseau syndrome (also called thrombophlebitis migrans), which refers to recurrent or migratory venous thrombosis associated with malignancy 2, 3, 4, 5, 6. Despite sharing the same eponym, these are entirely different clinical entities:

  • Trousseau sign: Neuromuscular manifestation of hypocalcemia 1
  • Trousseau syndrome: Paraneoplastic hypercoagulable state with venous thromboembolism 2, 4, 5, 6

Diagnostic Utility and Sensitivity

Trousseau sign serves as a bedside test for latent tetany, though its sensitivity varies. The sign is more specific than Chvostek's sign for detecting hypocalcemia-induced neuromuscular irritability 1. When positive, it should prompt immediate measurement of:

  • Corrected total serum calcium 1
  • Ionized calcium (if available) 1
  • Intact parathyroid hormone (PTH) 1
  • Phosphorus levels 1
  • Magnesium levels (as hypomagnesemia can cause hypocalcemia) 1

Common Pitfalls

A negative Trousseau sign does not exclude hypocalcemia, as the test detects latent tetany which may not be present in all hypocalcemic patients 1. Additionally, the test requires maintaining cuff inflation for the full 3 minutes—premature deflation may yield false-negative results 1.

The presence of peripheral vascular disease or severe hypertension may make the test difficult to interpret or contraindicate its performance due to risk of ischemic injury 1.

Management Implications

When Trousseau sign is present in CKD patients with corrected total calcium <8.4 mg/dL (2.10 mmol/L), immediate calcium supplementation is indicated regardless of PTH levels 1. The target range for corrected total calcium in CKD stage 5 patients should be 8.4 to 9.5 mg/dL (2.10 to 2.37 mmol/L), preferably toward the lower end of this range 1.

Total elemental calcium intake (including dietary sources and calcium-based phosphate binders) should not exceed 2,000 mg/day to avoid hypercalcemia and vascular calcification 1.

Related Questions

Can I order a Cologuard test for a patient presenting with blood in the stool?
Which suture materials and sizes are optimal for different wound types (e.g., superficial clean lacerations, deeper moderate‑tension wounds, contaminated or high‑tension wounds, and fascia or tendon repairs)?
In a 72‑year‑old smoker undergoing low‑dose computed tomography (LDCT) screening who now has a new 6 × 9 mm right upper‑lobe nodule minimally avid on positron emission tomography (PET) and a new 3 mm left upper‑lobe nodule, with other stable nodules, should these nodules be followed with yearly imaging or a more frequent surveillance protocol?
Can hair transplant surgery affect the ventromedial prefrontal cortex in a patient?
What are the common laboratory abnormalities after massive transfusion (≥10 units packed red cells within 24 hours)?
Can a pregnant woman safely use diclofenac for pain or inflammation, and what are the associated risks and recommended alternatives?
What is the appropriate cefepime dosing regimen for a 38‑year‑old patient with febrile Escherichia coli pyelonephritis who remains febrile on ceftriaxone, including renal function–based dose adjustments?
What is the mechanism of sexual dysfunction associated with escitalopram use?
What are the recommended precautions and management strategies to prevent iodinated contrast‑induced nephropathy, especially when using iso‑osmolar agents such as iodixanol in patients with impaired renal function?
Which medications are known to precipitate toxic megacolon?
Is gene therapy recommended for treating heart failure, and when should it be considered?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.